Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTE
1576
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
| $1.1M | ﹤0.01% |
106,000
| – | – |
|
|
RXDX
1577
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.09M | ﹤0.01% |
10,203
+5,617
| +122% | +$647K |
|
1578
LGI Homes
LGIH
$1.32B
| $1.09M | ﹤0.01% |
9,583
+174
| +2% | +$18.9K |
|
1579
LivaNova
LIVN
$4.45B
| $1.09M | ﹤0.01% |
25,000
+15,098
| +152% | +$764K |
|
1580
Cal-Maine
CALM
$3.86B
| $1.09M | ﹤0.01% |
17,837
+9,005
| +102% | +$502K |
|
1581
Affirm
AFRM
$24.6B
| $1.09M | ﹤0.01% |
+96,286
| New | +$1.21M |
|
|
EQC
1582
DELISTED
Equity Commonwealth
EQC
| $1.08M | ﹤0.01% |
52,275
+30,556
| +141% | +$709K |
|
1583
Transmedics
TMDX
$3.02B
| $1.08M | ﹤0.01% |
14,234
+9,217
| +184% | +$637K |
|
1584
Annaly Capital Management
NLY
$17.4B
| $1.08M | ﹤0.01% |
56,330
+505
| +0.9% | +$10.7K |
|
1585
WD-40
WDFC
$3.12B
| $1.08M | ﹤0.01% |
6,050
+3,270
| +118% | +$564K |
|
|
PDCO
1586
DELISTED
Patterson Companies, Inc.
PDCO
| $1.07M | ﹤0.01% |
40,105
+20,964
| +110% | +$589K |
|
1587
Acushnet Holdings
GOLF
$5.2B
| $1.07M | ﹤0.01% |
21,066
+6,206
| +42% | +$301K |
|
1588
Macerich
MAC
$6.99B
| $1.07M | ﹤0.01% |
101,015
+59,681
| +144% | +$709K |
|
|
RCM
1589
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.07M | ﹤0.01% |
70,978
+46,101
| +185% | +$631K |
|
1590
Surgery Partners
SGRY
$2.01B
| $1.06M | ﹤0.01% |
30,907
+16,182
| +110% | +$525K |
|
|
AMED
1591
DELISTED
Amedisys
AMED
| $1.06M | ﹤0.01% |
14,437
-6,840
| -32% | -$592K |
|
1592
Universal Health Services
UHS
$10.2B
| $1.06M | ﹤0.01% |
8,354
+2,653
| +47% | +$366K |
|
1593
Kontoor Brands
KTB
$4.51B
| $1.06M | ﹤0.01% |
21,900
+11,979
| +121% | +$568K |
|
1594
Southwest Airlines
LUV
$22B
| $1.05M | ﹤0.01% |
32,408
+15,217
| +89% | +$518K |
|
1595
EQT Corp
EQT
$33.8B
| $1.05M | ﹤0.01% |
33,041
+11,265
| +52% | +$361K |
|
|
BPMC
1596
DELISTED
Blueprint Medicines
BPMC
| $1.05M | ﹤0.01% |
23,431
+12,221
| +109% | +$551K |
|
|
WEL
1597
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.05M | ﹤0.01% |
100,000
| – | – |
|
1598
CVB Financial
CVBF
$4.05B
| $1.05M | ﹤0.01% |
63,100
+36,900
| +141% | +$841K |
|
1599
Materion
MTRN
$5.9B
| $1.05M | ﹤0.01% |
9,061
+4,932
| +119% | +$494K |
|
1600
Alarm.com
ALRM
$2.72B
| $1.05M | ﹤0.01% |
20,892
-39,358
| -65% | -$2.03M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.